Issuer positions
1
Reporting Owner Activity for Ph.D. Daniel Billen
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
Aurinia Pharmaceuticals Inc.
Disclosed value
$161.5K
Recent activity
Available
- Forms 3/4/5 ownership summary
-
Estimated owner position value
$161,529
Estimated from parsed Forms 3/4/5 when the filing discloses enough holding data.
Issuer positions
1
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest issuer position
Aurinia Pharmaceuticals Inc. (AUPH)
$161.5K estimated from parsed owner filings.
Latest owner filing
22 May 2024
Most recent owner-level filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
- Verify the source filing before treating any owner position as current.
- Location
- Victoria, British Columbia, Canada
- SEC signature
- /s/ Daniel Billen, Ph.D.
- Source evidence
- Open source filing history
SEC ownership signals
1 fact
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Follow Filing Activity
Follow Ph.D. Daniel Billen and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Ph.D. Daniel Billen
AUPH
Forms 3/4/5
Aurinia Pharmaceuticals Inc.
- Relationship
- Director
- Holdings value
- $161,529
- Past year net change
- Change %
- Report period
- 21 May 2024
Insider Transactions Reported by Ph.D. Daniel Billen:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.